Success Metrics

Clinical Success Rate
88.2%

Based on 15 completed trials

Completion Rate
88%(15/17)
Active Trials
5(19%)
Results Posted
20%(3 trials)
Terminated
2(8%)

Phase Distribution

Ph phase_2
5
19%
Ph phase_3
2
8%
Ph phase_1
4
15%
Ph phase_4
11
42%
Ph not_applicable
3
12%

Phase Distribution

4

Early Stage

5

Mid Stage

13

Late Stage

Phase Distribution25 total trials
Phase 1Safety & dosage
4(16.0%)
Phase 2Efficacy & side effects
5(20.0%)
Phase 3Large-scale testing
2(8.0%)
Phase 4Post-market surveillance
11(44.0%)
N/ANon-phased studies
3(12.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

15 of 17 finished

Non-Completion Rate

11.8%

2 ended early

Currently Active

5

trials recruiting

Total Trials

26

all time

Status Distribution
Active(6)
Completed(15)
Terminated(2)
Other(3)

Detailed Status

Completed15
Recruiting3
unknown3
Active, not recruiting2
Terminated2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
26
Active
5
Success Rate
88.2%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (16.0%)
Phase 25 (20.0%)
Phase 32 (8.0%)
Phase 411 (44.0%)
N/A3 (12.0%)

Trials by Status

completed1558%
recruiting312%
active_not_recruiting28%
unknown312%
terminated28%
not_yet_recruiting14%

Recent Activity

Clinical Trials (26)

Showing 20 of 26 trialsScroll for more
NCT06470100Phase 4

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Knee Arthroplasty

Completed
NCT07023107Phase 4

NLR and PLR Levels Following PENG Block in Hip Arthroplasty

Completed
NCT06202378Phase 2

Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke

Completed
NCT04036305

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

Active Not Recruiting
NCT06447415Phase 1

Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial

Completed
NCT07191899Phase 1

To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension

Recruiting
NCT06192927Phase 2

Efficacy and Safety of TenoMiR in Lateral Epicondylitis

Completed
NCT06304298Phase 4

NLR and PLR Levels Following IPACK Block in Knee Arthroplasty

Completed
NCT06351150Phase 3

Efficacy and Safety of Angiotensin II Injection Versus Placebo in Patients With Refractory Distributed Shock

Recruiting
NCT05603741Phase 4

Local Anesthetic Response in Ehlers-Danlos Syndrome (EDS) and Healthy Volunteers

Active Not Recruiting
NCT05555758Phase 1

Aom0319 SAD Study in Healthy Subjects

Completed
NCT05072821Phase 4

Botulinum Toxin Type a Injection to Prevent Keloid Recurrence

Completed
NCT06233617Phase 4

Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery

Recruiting
NCT06255366Phase 4

Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion

Not Yet Recruiting
NCT03824808Phase 4

Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery

Terminated
NCT05407597Phase 2

Inhibition of Bradykinin in COVID-19 Infection With Icatibant

Completed
NCT03223298Phase 3

Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles

Completed
NCT04652427Not Applicable

Application of Dexmedetomidine Hydrochloride Injection in Anesthesia for Patients Without Tracheal Intubation

Unknown
NCT04365010Phase 4

Low-chlorine Vs High-chlorine Crystalloids in Septic Shock Adults

Unknown
NCT02077920Phase 2

Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
26